All news

Vertex Pharmaceuticals appoints Daniel Brennan to board of directors By Investing.com

Alpha Vantage · Investing.com India · · AI-summarised by FinFlash

Vertex Pharmaceuticals has announced the appointment of Daniel Brennan to its board of directors, increasing the board to eleven members. Brennan, formerly Executive Vice President and CFO at Boston Scientific Corporation, will also join the company’s Audit and Finance Committee. This move comes as Vertex shares show strong performance and the company continues to advance its treatment pipeline.

Read original source

VRTX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.